查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825373

手术模拟市场：2025-2030 年预测

Surgical Simulation Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

手术模拟市场预计将从 2025 年的 4.0228 亿美元成长到 2030 年的 8.52234 亿美元，复合年增长率为 16.20%。

手术模拟是一种电脑技术，旨在培训医疗专业人员，无需患者或动物参与训练。此技术利用动作感测器和3D图形来创造逼真的手术体验，让使用者在对虚拟器官进行完整手术的同时，能够亲身感受组织和器官的特性。这种身临其境型训练环境有助于医生从错误中学习，同时避免危及患者的生命，从而最大限度地减少医疗失误和感染率。

市场驱动因素

慢性病盛行率上升

全球慢性疾病患者数量的不断增长是手术模拟市场成长的主要驱动力。根据世界卫生组织 (WHO) 的数据，慢性病（非传染性疾病）占全球死亡人数的 71%，相当于每年 4,100 万人死亡。世界经济论坛指出，全球三分之一的成年人同时患有多种慢性疾病，包括心血管疾病、糖尿病、忧郁症、癌症或多种疾病同时存在。

非传染性疾病占全球疾病负担的一半以上。慢性病的快速成长使得全球医疗体系认识到手术模拟技术的重要性，它有助于培养高素质的医疗专业人员，应对需要手术介入的复杂疾病。

人口结构转变与老化

随着全球人口快速老化，世界正迎来一个关键的人口里程碑，这不仅需要技术主导的医疗保健系统，还需要尖端的医疗培训。世界卫生组织 (WHO) 预测，65 岁及以上人口将从 2010 年的 5.24 亿增加到 2050 年的近 15 亿，其中大部分成长发生在开发中国家。

人口老化持续加剧，为世界各地的医疗保健系统带来挑战。根据人口问题研究所的数据，日本65岁及以上人口占总人口的28%，其次是义大利、芬兰和希腊。中国65岁以上人口占总人口的12%，美国65岁以上人口占总人口的16%。

人口老化的持续存在对技术主导的手术模拟的需求，以便在全球范围内培训更多的外科医生，并透过合格的医疗专业人员有效地满足医疗保健需求。

开发中国家的认可与采用

新兴国家对训练技术的认知度迅速提升，为外科模拟市场的发展带来了巨大的机会。新兴经济体举办的培训计画正在不断提升人们对外科模拟训练益处的认知。

世界卫生组织（WHO）报告称，心血管疾病每年导致1790万人死亡，癌症导致960万人死亡。大多数慢性疾病患者居住在开发中国家，WHO估计，其中85%的死亡发生在低收入和中等收入国家。快速、无计划的都市化和不健康生活方式的全球化是造成这些统计数据的重要原因。

为了满足日益增长的改善医疗保健系统的需求，新兴国家必须采用技术主导的医疗保健设施，从传统医疗系统转型，并培训更多的外科医生。

竞争性投资与市场开发

日益激烈的竞争和不断增长的投资正透过策略发展倡议推动手术模拟市场的成长。主要的市场参与者包括CAE Inc.、Simulab Corporation、3D Systems, Inc.和MEDICAL-X，它们正在实施各种发展策略，以在市场中占据优势。

预计北美将占据外科手术模拟市场的重要份额。由于高科技发展和人口老化，亚太市场预计将实现成长。在政府资助下，学术和研究机构正在迅速扩张，从而促进了外科手术培训的普及和外科医生水平的提高。

区域市场分析

从地理市场分布来看，北美将保持其重要地位，而亚太地区则显示出强劲的成长潜力。政府对学术和研究机构的资助为教育和医疗机构采用手术模拟技术创造了有利条件。

市场展望

手术模拟市场受益于医疗保健领域的基本趋势，包括慢性病盛行率上升、人口老化以及医学教育技术的进步。医疗保健系统面临的压力、培训需求和技术力的结合，使得手术模拟成为全球医疗保健市场现代医学教育和专业发展的重要组成部分。

该技术解决了医疗保健领域的重要挑战，同时提供了安全且经济高效的培训解决方案，透过提高医护人员的技能和减少医疗错误来改善手术效果。

本报告的主要优点

  • 深入分析：深入了解主要和新兴地区的市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策，并在动态环境中开闢新的业务流和收益。
  • 适合广泛的使用者：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具有成本效益的。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是财务状况和关键发展）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章 手术模拟市场（按产品）

  • 介绍
  • 腹腔镜
  • 神经系统
  • 妇科
  • 心血管系统
  • 关节镜
  • 内视镜检查
  • 其他的

第六章：手术模拟市场（依最终用户划分）

  • 介绍
  • 医院
  • 研究和学术机构
  • 外科诊所
  • 军事组织

7. 手术模拟市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章：公司简介

  • CAE Inc.
  • Gaumard Scientific Company, Inc
  • Simulab Corporation
  • Surgical Science Sweden AB
  • 3B Scientific
  • Simendo BV
  • 3D Systems, Inc
  • VirtaMed AG
  • MEDICAL-X
  • OSSim Tech

第十章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611125

The surgical simulation market is expected to grow from USD 402.280 million in 2025 to USD 852.234 million in 2030, at a CAGR of 16.20%.

Surgical simulation represents a computer technology developed to train medical practitioners without requiring patients or animals for training purposes. The technology utilizes motion sensors and three-dimensional graphics to create realistic surgical experiences, enabling users to perform complete surgeries on virtual organs while physically sensing tissue and organ characteristics. This immersive training environment helps minimize medical errors and infection rates by allowing trainees to learn from mistakes without risking patient lives.

Market Drivers

Rising Chronic Disease Prevalence

The increasing number of chronic disease cases worldwide represents a major driver for surgical simulation market growth. According to the World Health Organization, chronic diseases (non-communicable diseases) account for 71% of global deaths, equivalent to 41 million annual deaths. Asian countries are experiencing chronic diseases as a growing health concern, with the World Economic Forum noting that one in three adults worldwide has multiple chronic conditions including cardiovascular disease, diabetes, depression, cancer, or combinations of multiple diseases simultaneously.

Non-communicable diseases represent more than half the global disease burden. This surge in chronic diseases has led the global healthcare system to recognize the critical importance of surgical simulation technology for training qualified medical professionals capable of addressing complex medical conditions requiring surgical intervention.

Demographic Transition and Aging Population

The world approaches a significant demographic milestone with rapidly aging populations globally, necessitating both technology-driven healthcare systems and cutting-edge medical training. The World Health Organization projects the population aged 65 or older will grow from an estimated 524 million in 2010 to nearly 1.5 billion by 2050, with most increases occurring in developing countries.

This continuously aging population challenges healthcare systems worldwide. The dramatic rise in elderly populations is most prominent in Asia followed by Europe, according to Population Reference Bureau data showing Japan with 28% of population aged 65 and above, followed by Italy, Finland, and Greece. China has 12% of population and the United States has 16% of population aged 65 and above.

The continuous population aging creates demand for technology-driven surgical simulation to train more surgeons globally, ensuring healthcare demand is effectively met through qualified medical professionals.

Developing Country Awareness and Adoption

Developing countries present significant opportunities for surgical simulation market expansion as awareness about training techniques rapidly increases. Development programs organized in developing economies spread awareness about surgical simulation training benefits.

The World Health Organization reports annual cardiovascular disease mortality at 17.9 million deaths, while cancer claims 9.6 million lives annually. Most chronic disease sufferers reside in developing countries, with WHO estimates showing 85% of these deaths occurring in low- and middle-income countries. Rapid unplanned urbanization and globalization of unhealthy lifestyles contribute prominently to these statistics.

Developing countries must adopt technology-driven healthcare facilities, transition toward conventional medical systems, and train more surgeons to meet growing demand for improved healthcare systems.

Competitive Investment and Market Development

Rising competition and investment boost surgical simulation market growth through strategic development initiatives. Prominent market players include CAE Inc., Simulab Corporation, and 3D Systems, Inc. MEDICAL-X, implementing various development strategies to achieve competitive market advantages.

North America is forecasted to account for considerable surgical simulation market share. The Asia-Pacific market demonstrates projected growth due to high technological developments and aging population demographics. Academic and research institutes are expanding rapidly due to government funding, leading to increased surgical training adoption and enhanced surgeon proficiency.

Geographic Market Analysis

Regional market distribution shows North America maintaining significant market presence while Asia-Pacific regions demonstrate strong growth potential. Government funding support for academic and research institutions creates favorable conditions for surgical simulation technology adoption across educational and healthcare facilities.

Market Outlook

The surgical simulation market benefits from fundamental healthcare trends including chronic disease prevalence, demographic aging, and technological advancement in medical education. The combination of healthcare system pressures, training requirements, and technological capabilities positions surgical simulation as an essential component of modern medical education and professional development across global healthcare markets.

This technology addresses critical healthcare challenges while providing safe, cost-effective training solutions that improve surgical outcomes through enhanced practitioner skills and reduced medical errors.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Surgical Simulation Market Segments:

By Product

  • Laparoscopic
  • Neurological
  • Gynecological
  • Cardiovascular
  • Arthroscopic
  • Endoscopic
  • Others

By End-User

  • Hospitals
  • Research and Academic Institutes
  • Surgical Clinics
  • Military Organizations

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SURGICAL SIMULATION MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Laparoscopic
  • 5.3. Neurological
  • 5.4. Gynecological
  • 5.5. Cardiovascular
  • 5.6. Arthroscopic
  • 5.7. Endoscopic
  • 5.8. Others

6. SURGICAL SIMULATION MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Research and Academic Institutes
  • 6.4. Surgical Clinics
  • 6.5. Military Organizations

7. SURGICAL SIMULATION MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. CAE Inc.
  • 9.2. Gaumard Scientific Company, Inc
  • 9.3. Simulab Corporation
  • 9.4. Surgical Science Sweden AB
  • 9.5. 3B Scientific
  • 9.6. Simendo B.V.
  • 9.7. 3D Systems, Inc
  • 9.8. VirtaMed AG
  • 9.9. MEDICAL-X
  • 9.10. OSSim Tech

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations